This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CHARLES SYKES, M.D.; JULIAN R. BECKWITH, M.D.; WILLIAM H. MULLER, M.D.; J. EDWIN WOOD, JR., M.D.

Arch Intern Med. 1962;110(1):113-116.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Severe infections due to the Pseudomonas aeruginosa organism were rare before the use of antibiotics¹ and usually occurred in debilitated patients or following instrumentation of the urinary tract.^2,3 Since penicillin and broad-spectrum antibiotics have been introduced, there have been reports that the Pseudomonas organism has emerged to produce serious infections.^4-6 These infections are difficult to treat because the organism is resistant to most antibiotics. Sensitivity to polymyxin B sulfate, neomycin sulfate, and streptomycin has been reported, but resistance to the latter 2 develops rapidly.^7-9 Even though in vitro sensitivity to polymyxin B sulfate can be demonstrated, eradication of the organism from a fresh blood clot has been unsuccessful.⁸

Twenty-four cases of endocarditis due to Pseudomonas aeruginosa have been reported.^2,10-17 Seven of these developed after surgery for either acquired or congenital heart disease. Six of these 7 cases died. One recovered after removal of a . . . [Full Text PDF of this Article]

Author Affiliations
NEW BEDFORD, MASS.; CHARLOTTESVILLE, VA.

From the Department of Medicine and the Department of Surgery, University of Virginia School of Medicine, Charlottesville.

Footnotes
Submitted for publication April 17, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?